Antenatal iron supplementation, FGF23, and bone metabolism in Kenyan women and their offspring: secondary analysis of a randomized controlled trial

Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low- and middle-income countries

(2018) Daniel E. Roth et al.   Annals of the New York Academy of Sciences

The effects of maternal iron deficiency on infant fibroblast growth factor-23 and mineral metabolism

(2016) V.S. Braithwaite et al.   BONE

Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study

(2016) Nao Souma et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Plasma fibroblast growth factor 23 concentration and iron status. Does the relationship exist in the elderly population?

(2015) Maria Bożentowicz-Wikarek et al.   CLINICAL BIOCHEMISTRY

Effect of Daily Antenatal Iron Supplementation onPlasmodiumInfection in Kenyan Women

(2015) Martin N. Mwangi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Coupling fibroblast growth factor 23 production and cleavage

(2014) Myles Wolf et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Neonatal Iron Deficiency Causes Abnormal Phosphate Metabolism by Elevating FGF23 in Normal and ADHR Mice

(2013) Erica L Clinkenbeard et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Combined Food and Micronutrient Supplements during Pregnancy Have Limited Impact on Child Blood Pressure and Kidney Function in Rural Bangladesh

(2013) Sophie Hawkesworth et al.   JOURNAL OF NUTRITION

Iron status and fibroblast growth factor-23 in Gambian children

(2012) Vickie Braithwaite et al.   BONE

Nutritional rickets around the world

(2012) Ann Prentice   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Enhanced induction of Cyp24a1 by FGF23 but low serum 24,25-dihydroxyvitamin D in CKD: implications for therapy

(2012) Adriana S. Dusso et al.   KIDNEY INTERNATIONAL

Calcium economy in human pregnancy and lactation

(2012) Hanna Olausson et al.   NUTRITION RESEARCH REVIEWS

Iron Modifies Plasma FGF23 Differently in Autosomal Dominant Hypophosphatemic Rickets and Healthy Humans

(2011) Erik A. Imel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice

(2011) E. G. Farrow et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The analysis of 2 × 2 contingency tables-Yet again

(2011) John T. E. Richardson   STATISTICS IN MEDICINE

Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation

(2009) R. Goetz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

FGF23 is elevated in Gambian children with rickets

(2007) Ann Prentice et al.   BONE